Clinical Trial

Pre-Exposure Prophylaxis to Prevent HIV

Study Description

IN-US-276-1340: Pre-Exposure Prophylaxis to Prevent HIV Acquisition in US Women: A Demonstration Project

The overall aim of this study is to assess attitudes toward PrEP, feasibility of Truvada PrEP procurement through the established access procedures, and adherence to Truvada PrEP among US women at risk for HIV acquisition.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - tenofovir disoproxil and emtricitabine

Pre-exposure Prophylaxis with Truvada will be distributed to all participants eligible to receive PrEP.

Additional Information

Official Study Title

IN-US-276-1340: Pre-Exposure Prophylaxis to Prevent HIV Acquisition in US Women: A Demonstration Project

Clinical Trial ID

NCT03058835

ParticipAid ID

qaQGLd